Price $17.49 |
Market Cap
1.07B
|
Sector Health Care |
Div. Growth
-100.00%
|
|
P/E
49.2
|
P/B
5.13
|
P/S
5.14
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
38.6
|
Op. Cash Flow
30.5K
|
FCF
0.6
|
|
Op. Margin
14.40%
|
Net Margin
10.50%
|
ROE
10.90%
|
ROI
9.60%
|
|
ROA
6.50%
|
EPS Growth
-22.80%
|
Current Ratio
6.9
|
Debt/Equity
39.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | $11.72 | - | - | 12.39B | Strong Buy |
| Digirad Corporation (DRAD) | $3.34 | - | - | 12.6M | Strong Buy |
| Pacific Biosciences of Califor (PACB) | $4.47 | - | - | 581.8M | Strong Buy |
| Amneal Pharmaceuticals Inc (AMRX) | $4.22 | - | - | 1.31B | Strong Buy |
| Daxor Corporation (DXR) | $16.79 | - | - | 69.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
